BTI
NVAX icon

Blue Trust Inc’s Novavax NVAX Stock Holding History

Blue Trust Inc’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471 Hold
50
– – ﹤0.01% 2359
2026
Q1 		$407 Hold
50
– – ﹤0.01% 2364
2025
Q4 		$336 Hold
50
– – ﹤0.01% 2444
2025
Q3 		$434 Hold
50
– – ﹤0.01% 2441
2025
Q2 		$315 Hold
50
– – ﹤0.01% 2354
2025
Q1 		$321 Hold
50
– – ﹤0.01% 2399
2024
Q4 		$402 Hold
50
– – ﹤0.01% 2342
2024
Q3 		$633 Sell
50
-59
-54% -$762 ﹤0.01% 2769
2024
Q2 		$521 Buy
109
+59
+118% +$594 ﹤0.01% 2611
2024
Q1 		$239 Sell
50
-26
-34% -$121 ﹤0.01% 2062
2023
Q4 		$0 Buy
+76
New +$465 ﹤0.01% 2638
2023
Q3 		– Sell
-1
Closed – – 2217
2023
Q2 		$0 Hold
1
– – ﹤0.01% 2368
2023
Q1 		$0 Sell
1
-11
-92% -$101 ﹤0.01% 2532
2022
Q4 		$0 Sell
12
-6
-33% -$106 ﹤0.01% 2391
2022
Q3 		$1K Buy
+18
New +$780 ﹤0.01% 1970

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Blue Trust Inc's NVAX Position: Q2 2026 in Review

Blue Trust Inc held its Novavax (NVAX) position steady in Q2 2026 at 50 shares worth $471. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

Blue Trust Inc first reported a position in NVAX in Q3 2022 and has held it in 15 quarters since. The position peaked at $1K in Q3 2022. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Blue Trust Inc held 50 shares of Novavax worth $471 as of Q2 2026.
  • Blue Trust Inc left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2359 holding.
  • Blue Trust Inc first reported a position in Novavax in Q3 2022 and has held it in 15 quarters since.
  • Blue Trust Inc's Novavax position peaked at $1K in Q3 2022.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.